Your browser doesn't support javascript.
Potential role of IFN-α in COVID-19 patients and its underlying treatment options.
Yang, Lei; Wang, Jianhui; Hui, Pei; Yarovinsky, Timur O; Badeti, Saiaditya; Pham, Kien; Liu, Chen.
  • Yang L; Department of Pathology, Yale School of Medicine, New Haven, CT, 06511, USA.
  • Wang J; Department of Pathology, Yale School of Medicine, New Haven, CT, 06511, USA.
  • Hui P; Department of Pathology, Yale School of Medicine, New Haven, CT, 06511, USA.
  • Yarovinsky TO; Department of Pathology, Yale School of Medicine, New Haven, CT, 06511, USA.
  • Badeti S; Department of Pathology, Rutgers New Jersey Medical School, Newark, NJ, 07103, USA.
  • Pham K; Department of Pathology, Yale School of Medicine, New Haven, CT, 06511, USA. kien.pham@yale.edu.
  • Liu C; Department of Pathology, Yale School of Medicine, New Haven, CT, 06511, USA. chen.liu@yale.edu.
Appl Microbiol Biotechnol ; 105(10): 4005-4015, 2021 May.
Article in English | MEDLINE | ID: covidwho-1216211
ABSTRACT
The coronavirus disease (COVID-19) caused by a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread rapidly worldwide. Given that this contagious viral outbreak is still unfolding, it is urgent to understand the pathogenesis of SARS-CoV-2 infection and explore effective treatments to protect patients from developing a severe illness related to COVID-19. Recently, IFN-α has been considered a potential therapeutic strategy to treat COVID-19 disease, mainly because the innate immune system rapidly produces IFN-α as the first line of defense to combat viral infections. However, IFN-α can also play a role in immunoregulatory effects, causing pathogenic damage and uncontrolled inflammatory responses. There are 13 human IFN-α subtypes that bind to the same receptor and induce different interferon-stimulated gene (ISG) expression, regulating various antiviral and immunoregulatory effects. The varying degrees of inflammatory regulations may raise concerns about the possible side effects to enlarge the inflammatory responses, exacerbating the severity of infection. Thus, the analysis of various IFN-α subtype induction during SARS-CoV-2 infection is necessary in exploring the mechanism of COVID-19 pathogenesis. This review summarizes the current understanding of IFN-α in the pathogenesis of respiratory virus diseases and IFN-α based clinical intervention used in SARS-CoV-2 infection and other respiratory virus diseases. Besides, new ideas in selecting suitable IFN-α subtypes or combinations as drug candidates for viral infection treatment will also be discussed.Key Points• IFN-α plays an important role in anti-viral and immunoregulatory effects in COVID-19 patients caused by SARS-CoV-2.• The uncontrolled inflammation and disease severity correlated to the diversity of IFN-α subtype induction.• Selecting suitable IFN-α subtypes or combinations as drug candidates will be beneficial for the treatment of patients with COVID-19.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Appl Microbiol Biotechnol Year: 2021 Document Type: Article Affiliation country: S00253-021-11319-6

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Appl Microbiol Biotechnol Year: 2021 Document Type: Article Affiliation country: S00253-021-11319-6